Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost

American Journal of Ophthalmology

Volumn 128, Issue 6, 1999, Pages 692-696

  Stewart, William C ^a,b   Day, Douglas G ^c   Sharpe, Elizabeth D ^d   Dubiner, Harvey B ^e   Holmes, Keri T ^a   Stewart, Jeanette A ^a  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Omni Eye Services   (United States)

^d Ophthalmology Consultants   (United States)

^e Clayton Eye Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; TIMOLOL; TIMOLOL MALEATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EYE TOXICITY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MULTICENTER STUDY; NAUSEA; OPEN ANGLE GLAUCOMA; OPHTHALMOSCOPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT INFECTION; VISUAL ACUITY;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GELS; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC; SAFETY; TIMOLOL; TREATMENT OUTCOME;

EID: 0033429688     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00237-8     Document Type: Article

References (18)

1. Stewart W.C. Prostaglandin analogues their usage and benefits in glaucoma treatment . Ophthalmic Pract. 14:1996;48-55.
2. Stewart W.C., Leland T.M., Cate E.A., Stewart J.A. Efficacy and safety of timolol solution once daily vs. timolol gel in treating elevated IOP. J Glaucoma. 7:1998;402-407.
3. Stewart W.C., Sine C., Cate E., Minno G.E., Hunt H.H. Daily cost of beta-adrenergic blocker therapy. Arch Ophthalmol. 115:1997;853-856.
4. Mao L.K., Stewart W.C., Shields M.D. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol. 111:1991;51-55.
5. Book SA. Essentials of statistics. New York: McGraw Hill Book Company, 1978:117-122, 205-215.
6. Rosner B. Fundamentals of biostatistics. 1982;301-304 Duxbury Press, Boston.
7. Siegel S. Nonparametric statistics series in psychology . 1956;63-67 McGraw Hill, New York.
8. A multi-dose, double-masked, parallel, active-treatment-controlled, multi-clinic study of 0.5% Timoptic-XE and 0.5% Timoptic in patients with elevated intraocular pressure (IOP). Merck & Co, Inc, Blue Bell, Pennsylvania, Internal Report DA-TIMXE10.
9. Wandel T., Fishman D., Novack G.D., Kelley E., Chen K.S. Ocular hypotensive efficacy of 0.25% levobunolol instilled once daily. Ophthalmology. 95:1988;252.
10. Rakofsky S.I., Melamed S., Cohen J.S., et al. A comparison of the ocular hypotensive efficacy of once-daily and twice-daily levobunolol treatment. Ophthalmology. 96:1989;8.
11. Silverstone D., Zimmerman T., Choplin N., et al. Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure. Am J Ophthalmol. 112:1991;56-60.
12. Wandel T., Charap A.D., Lewis R.A., et al. Glaucoma treatment with once-daily levobunolol. Am J Ophthalmol. 101:1986;298.
13. Cantor L.B., Alvi N.P., Hoop J.S., et al. Comparison of once daily levobunolol 0.5% versus timolol XE 0.5% for the control of intraocular pressure and patient comfort. ARVO abstract. Invest Ophthalmol Vis Sci. 38:(suppl 4):1997;S558.
14. Stewart W.C., Cate E.A., Stewart J.A. Systemic beta-blockade with once daily Betimol™ or Timoptic-XE™ J Ocul Pharm Ther. 127:1999;142-147.
15. Johnsson G., Regardh C.-G. Clinical pharmacokinetics of β-adrenoreceptor blocking drugs. Clin Pharmacokine. 1:1976;233-263.
16. 2α analogue, and timolol in patients with elevated intraocular pressure. Br J Ophthalmol. 78:1994;899-902.
17. Alm A., Stjernschantz J. Effects on intraocular pressure and side-effects of 0.005% latanoprost applied once daily, evening or morning a comparison with timolol . Ophthalmology. 102:1995;1743-1752.
18. Topper J.E., Brubaker R.F. Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep. Invest Ophthalmol Vis Sci. 26:1985;1315-1319.